Published in Int J Mol Med on March 11, 2016
Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) (2017) 0.76
Dietary guidance and ileal enteroendocrine cells in patients with irritable bowel syndrome. Exp Ther Med (2016) 0.75
Enteroendocrine cells, stem cells and differentiation progenitors in rats with TNBS-induced colitis. Int J Mol Med (2016) 0.75
Effect of diet and individual dietary guidance on gastrointestinal endocrine cells in patients with irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
Dietary fiber in irritable bowel syndrome (Review). Int J Mol Med (2017) 0.75
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
The chromogranin-secretogranin family. N Engl J Med (2003) 4.28
Validity of a new food frequency questionnaire for pregnant women in the Norwegian Mother and Child Cohort Study (MoBa). Matern Child Nutr (2008) 2.15
Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion (2001) 2.05
Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr Opin Endocrinol Diabetes Obes (2008) 1.94
Statistical approaches for assessing the relative validity of a food-frequency questionnaire: use of correlation coefficients and the kappa statistic. Public Health Nutr (2003) 1.88
Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol (2010) 1.79
Synaptophysin and chromogranins/secretogranins--widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1989) 1.73
Review article: fructose malabsorption and the bigger picture. Aliment Pharmacol Ther (2007) 1.73
The "normal" endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci (2004) 1.55
Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med (2010) 1.44
Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences. Eur J Clin Nutr (2006) 1.39
Taste receptors in the gastrointestinal tract. IV. Functional implications of bitter taste receptors in gastrointestinal chemosensing. Am J Physiol Gastrointest Liver Physiol (2006) 1.35
Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev (1991) 1.29
Gut endocrine cell development. Mol Cell Endocrinol (2009) 1.29
Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol (2010) 1.23
Intestinal sensing of nutrients. Handb Exp Pharmacol (2012) 1.20
Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome. Scand J Gastroenterol (2010) 1.17
Nutrient Tasting and Signaling Mechanisms in the Gut III. Endocrine cell recognition of luminal nutrients. Am J Physiol (1999) 1.14
Molecular mechanisms of enteroendocrine differentiation. Ann N Y Acad Sci (1998) 1.09
Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol (1993) 1.07
Mindfulness-based stress reduction for the treatment of irritable bowel syndrome symptoms: a randomized wait-list controlled trial. Int J Behav Med (2013) 1.07
Chromogranin A promotes peptide hormone sorting to mobile granules in constitutively and regulated secreting cells: role of conserved N- and C-terminal peptides. J Biol Chem (2009) 1.05
Immunofluorescent localization of secretin and enteroglucagon in human intestinal mucosa. Scand J Gastroenterol (1971) 1.04
Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J Physiol Biochem (2008) 1.01
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
Ageing and endocrine cells of human duodenum. Mech Ageing Dev (1999) 0.99
Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep (2012) 0.99
Classification and functions of enteroendocrine cells of the lower gastrointestinal tract. Int J Exp Pathol (2011) 0.98
Glucose sensing by gut endocrine cells and activation of the vagal afferent pathway is impaired in a rodent model of type 2 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol (2011) 0.95
A randomized controlled trial of imipramine in patients with irritable bowel syndrome. World J Gastroenterol (2009) 0.95
Ghrelin in gastrointestinal diseases and disorders: a possible role in the pathophysiology and clinical implications (review). Int J Mol Med (2009) 0.95
Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep (2013) 0.94
The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity. Regul Pept (2009) 0.94
Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterol Res Pract (2014) 0.93
Cellular kinetics of gastrointestinal mucosa, with special reference to gut endocrine cells. Arch Histol Jpn (1983) 0.92
Chromogranin A cell density in the rectum of patients with irritable bowel syndrome. Mol Med Rep (2012) 0.92
Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions. Regul Pept (2009) 0.91
Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol (2014) 0.89
Dietary intakes in people with irritable bowel syndrome. BMC Gastroenterol (2011) 0.88
Taste, visceral information and exocrine reflexes with glutamate through umami receptors. J Med Invest (2009) 0.87
[Determination of placebo effect in irritable bowel syndrome]. Dtsch Med Wochenschr (2005) 0.87
Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome. Mol Med Rep (2013) 0.86
Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med (2014) 0.85
Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastroenterol Res Pract (2015) 0.84
Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats. Regul Pept (2008) 0.84
Increased gastric chromogranin A cell density following changes to diets of patients with irritable bowel syndrome. Mol Med Rep (2014) 0.83
Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr (2015) 0.81
Chromogranin A cells in the stomachs of patients with sporadic irritable bowel syndrome. Mol Med Rep (2014) 0.80
Effect of dietary management on the gastric endocrine cells in patients with irritable bowel syndrome. Eur J Clin Nutr (2014) 0.80
Reduction in duodenal endocrine cells in irritable bowel syndrome is associated with stem cell abnormalities. World J Gastroenterol (2015) 0.79
Functional bowel symptoms and diet. Intern Med J (2013) 0.78